ESPR Dividends Insights

ESPR pays dividends . Last paid amount was $3.16 at Jul 13, 2026. As of today, dividend yield (TTM) is 99.37%.

Dividend Score Premium

Avoid dividend cuts
with our Dividend Score

Start 7-Day Free Trial
AI Analysis AI Analysis of ESPR
AI-Powered Dividend Insights

Built on AI-powered analysis of yield strength, recent news, payout trends, and 10-year dividend growth consistency.

Dividend Yield Range

The Dividend Yield Range is the range of values in which a stock’s dividend yield has fluctuated within a specified period, often a year. It represents the variation between the highest and lowest dividend yields observed during that time frame.
Notice for ESPR: Ex-dividend date was Monday 13th July, 2026. The dividend was $3.16.
AI Analysis AI Analysis of ESPR
AI-Powered Market Insights
New!
Dividend Analysis

Key Stats

Dividend Yield (TTM) 99.37%
Frequency
1Y Growth 0%
Payout Ratio 0
Amount Per Share $3.16
Next Ex-Dividend Date Jul 13, 2026
Next Payment Date Jul 13, 2026

ESPR Dividend Payout History

To ensure a understanding of ESPR's dividend performance, consider examining the historical payout ratios and how they align with the company's earnings. Fluctuations in payout amounts may reflect changes in the company's dividend policy or earnings stability.


# Declaration Date Ex-Date Pay Date Amount Yield
1 Jul 13, 2026 Jul 13, 2026 Jul 13, 2026 $3.16 99.06%
Requires Login
Login

Dividend Sustainability

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. Overall, a more vigilant stance is recommended given the company's tentative dividend profile.

DSS - Sustainability score

Low (50.00%)

DSGP - Growth potential

No dividend expected

ESPR Dividend Calculator

Dividend Calculator is designed to forecast the potential returns from ESPR dividends based on your individual investment size or the number of shares you own. Simply enter your total investment amount to see the cumulative dividend payment you could receive over a specified period.
Read how to invest in ESPR stock here.

Comparing ESPR to Sector and Country

ESPR pays a solid dividend yield of 99.37%, which is higher than the average of the bottom 25% of dividend payers in the US market (0.584%). ESPR’s dividend yield is higher than the average of the top 25% of dividend payers in the Healthcare sector in the US market (8.87%).

ESPR Stock Competitors

Symbol Company Name Market Cap Amount Per Share Dividend Yield (TTM) Payout Ratio (TTM)
Esperion Therapeutics 661.15M $3.16 99.37% -

FAQ

What factors can affect the amount of ESPR's dividend payments?
The amount of ESPR's dividends can fluctuate based on several factors, including the company's financial performance, earnings, cash flow, capital requirements, and overall market conditions. Changes in ESPR sector's trends, interest rate shifts, and the company's operational adjustments can also influence dividend decisions.

Can dividends from ESPR stock be automatically reinvested?
If ESPR offers a Dividend Reinvestment Plan (DRIP), shareholders may have the option to automatically reinvest dividends to purchase additional shares. Please check with your brokerage for the availability and details of such a plan. Here's an easy guide on how to buy ESPR stock.

How often does ESPR pay dividend?
Esperion Therapeutics (ESPR) pays dividends . The most recent payout was on Jul 13, 2026. The upcoming dividend Ex Date is Jul 13, 2026, with an amount of $3.16.

How much does ESPR pays per share?
The last recorder (Jul 13, 2026) dividend per share was $3.16.

What is ESPR dividend growth rate?
Over the last year, Esperion Therapeutics has witnessed growth rate of 0% . Looking back over the past 3 years, this growth rate has been 0%. Furthermore, examining the past 5 years, Esperion Therapeutics has maintained an average Dividends Per Share Growth Rate of 0%.
Click to get the best stock tips daily for free!
ABOUT ESPERION THERAPEUTICS
Esperion Therapeutics
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascular disease or heterozygous familial hypercholesterolemia. The company has a license and collaboration a...
GOLDEN STAR
Ticker Change Signal Date
SRPT
$17.02
10.58% Jun 29
NMRK
$15.02
0.466% Jun 24
X
XMAX
$8.34
2.40% Jun 24
NESR
$25.07
12.49% Jun 23
CAG
$13.43
6.70% Jun 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE